[Therapeutic effects of a new psycholeptic agent (febarbamate, Solium) in pediatrics].
D001463:Barbiturates / Q000627:therapeutic use*; D002219:Carbamates / Q000627:therapeutic use; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy*; D004775:Enuresis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D013342:Stuttering / Q000188:drug therapy*; D013981:Tic Disorders / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D001463:Barbiturates; D002219:Carbamates; D014149:Tranquilizing Agents
Effetti terapeutici di un nuovo psicolettico (febarbamato Solium) nella patologia infantile.